Cargando…
Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
Autores principales: | Fiorino, Irene, Loconte, Filomena, Rucco, Anna Simona, Nico, Andrea, Vacca, Maddalena, Damiani, Elisabetta, Nettis, Eustachio, Caiaffa, Maria Filomena, Macchia, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221356/ https://www.ncbi.nlm.nih.gov/pubmed/25395932 http://dx.doi.org/10.5114/pdia.2014.44023 |
Ejemplares similares
-
Chronic urticaria reveals JAK2V617F positive essential thrombocythemia
por: Albanesi, Marcello, et al.
Publicado: (2021) -
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management
por: Magistà, Stefania, et al.
Publicado: (2020) -
Rapid desensitization for brentuximab vedotin (Adceteris(®)) allergy: a case report
por: Di Girolamo, Attilio, et al.
Publicado: (2018) -
Long term treatment with omalizumab in adolescent with refractory solar urticaria
por: Iannelli, Mauro, et al.
Publicado: (2021) -
269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012)